Trevi Therapeutics (TRVI) Institutional Ownership → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free TRVI Stock Alerts $2.77 -0.07 (-2.46%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Trevi Therapeutics (NASDAQ:TRVI)CurrentInstitutional OwnershipPercentage95.76%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$4.45MNumber ofInstitutional Sellers(last 12 months)8TotalInstitutional Outflows(last 12 months)$4.36M Get TRVI Insider Trade Alerts Want to know when executives and insiders are buying or selling Trevi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRVI Institutional Buying and Selling by Quarter Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. Trevi Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2024 Price T Rowe Associates Inc. MD13,561$47K0.0%N/A0.019% 5/14/2024 Propel Bio Management LLC260,000$897K0.5%N/A0.369% 5/10/2024 Vanguard Group Inc.2,303,648$7.95M0.0%+2.7%3.271% 5/7/2024 Oppenheimer & Co. Inc.60,415$208K0.0%N/A0.086% 5/7/2024 SG Americas Securities LLC14,592$50K0.0%-85.1%0.021% 5/1/2024 BNP Paribas Financial Markets20,577$71K0.0%-84.4%0.030% Get the Latest News and Ratings for TRVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/25/2024 Rosalind Advisors Inc.926,016$3.20M3.0%-50.3%1.343% 2/15/2024 Opaleye Management Inc.2,535,000$3.40M0.9%+48.6%3.970% 2/15/2024 Frazier Life Sciences Management L.P.7,381,090$9.89M0.5%+7.3%11.559% 2/5/2024 WealthTrust Axiom LLC63,500$85K0.0%-32.1%0.099% 1/12/2024 SG Americas Securities LLC98,253$132K0.0%+401.4%0.154% 1/4/2024 Trust Co. of Toledo NA OH36,502$49K0.0%-68.8%0.057% 11/13/2023 Silverarc Capital Management LLC927,415$2.02M0.6%+4.7%1.452% 10/20/2023 Trust Co. of Toledo NA OH117,145$255K0.1%-6.2%0.183% 10/13/2023 SG Americas Securities LLC19,597$43K0.0%N/A0.031% 9/21/2023 Barclays PLC14,052$34K0.0%N/A0.022% 8/11/2023 VR Adviser LLC3,422,397$8.18M1.3%+12.2%5.697% 8/11/2023 Tejara Capital Ltd180,227$431K0.2%-5.3%0.300% 8/4/2023 American International Group Inc.20,037$48K0.0%N/A0.033% 8/3/2023Innovis Asset Management LLC43,232$103K0.0%-50.5%0.072% 8/2/2023 MAI Capital Management1,534,652$3.67M0.1%-4.1%2.555% 7/10/2023 Trust Co. of Toledo NA OH124,857$298K0.1%+50.4%0.208% 5/12/2023 Tejara Capital Ltd190,218$352K0.2%+26.8%0.317% 5/10/2023 MAI Capital Management1,600,415$2.96M0.0%-7.0%2.664% 4/4/2023 Trust Co. of Toledo NA OH83,000$154K0.0%N/A0.138% 2/10/2023 Opaleye Management Inc.485,000$936K0.3%N/A0.809% 2/9/2023 MAI Capital Management1,720,676$3.32M0.1%-14.8%2.872% 2/3/2023 Frazier Life Sciences Management L.P.6,663,590$12.86M0.8%+23.3%11.121% 2/2/2023 Bailard Inc.21,200$41K0.0%N/A0.035% 2/1/2023 Bank of Montreal Can152,300$294K0.0%N/A0.254% 11/15/2022 TPG GP A LLC251,780$388K0.0%-94.2%0.571% 11/14/2022 Armistice Capital LLC864,000$1.33M0.0%+107.7%1.961% 11/14/2022 Altium Capital Management LP1,066,157$1.64M0.6%-17.0%2.419% 11/14/2022 Rubric Capital Management LP5,684,420$8.75M0.4%+219.6%12.899% 11/10/2022 Hillsdale Investment Management Inc.86,531$133K0.0%N/A0.196% 11/9/2022 Fairmount Funds Management LLC5,696,515$8.77M1.5%+250.7%12.926% 11/7/2022 Jump Financial LLC42,977$66K0.0%N/A0.098% 10/28/2022 Silverarc Capital Management LLC939,265$1.45M0.5%N/A2.131% 8/15/2022 Acuta Capital Partners LLC35,000$98K0.1%N/A0.090% 8/10/2022 Frazier Life Sciences Management L.P.1,171,627$3.29M0.3%N/A3.029% A once-in-a-century investment opportunity (Ad)It's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead.To get its name and ticker symbol for free - just click here.7/27/2022 WealthTrust Axiom LLC93,500$262K0.1%-5.1%0.242% 7/19/2022 MAI Capital Management2,040,009$5.73M0.1%+32.3%5.273% 5/10/2022 MAI Capital Management1,541,471$3.39M0.1%N/A3.985% 5/9/2022 WealthTrust Axiom LLC98,500$216K0.1%+245.6%0.255% 5/4/2022Commonwealth Equity Services LLC15,000$33K0.0%N/A0.049% 8/17/2021 Bridgeway Capital Management LLC34,600$78K0.0%-68.4%0.160% 8/16/2021 Alberta Investment Management Corp25,000$56K0.0%N/A0.116% 8/13/2021 Renaissance Technologies LLC92,600$208K0.0%-24.0%0.429% 5/21/2021 Citadel Advisors LLC10,617$29K0.0%N/A0.053% 5/18/2021 Citadel Advisors LLC10,617$29K0.0%N/A0.053% 5/13/2021 Renaissance Technologies LLC121,849$330K0.0%+374.1%0.611% 5/7/2021 BlackRock Inc.32,394$87K0.0%+40.6%0.163% 4/14/2021 WealthTrust Axiom LLC38,500$104K0.0%+234.8%0.193% 3/26/2021Susquehanna International Group LLP14,828$36K0.0%N/A0.081% 2/17/2021 Canada Pension Plan Investment Board15,000$36K0.0%N/A0.082% 2/10/2021 Renaissance Technologies LLC25,700$62K0.0%N/A0.140% 2/4/2021 WealthTrust Axiom LLC11,500$27K0.0%N/A0.063% 8/31/2020 Bridgeway Capital Management Inc.100,000$658K0.0%+33.3%0.548% 8/17/2020 Omega Fund Management LLC1,375,907$9.05M2.5%+8.9%7.711% 8/14/2020 Canada Pension Plan Investment Board40,000$263K0.0%N/A0.224% 8/14/2020TPG Group Holdings SBS Advisors Inc.4,824,883$31.75M0.6%-23.7%27.039% 8/5/2020 NEA Management Company LLC5,940,796$39.09M1.6%+33.8%33.293% 5/15/2020 Driehaus Capital Management LLC117,371$386K0.0%-6.1%0.658% (Data available from 1/1/2016 forward) TRVI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRVI shares? During the previous two years, 28 institutional investors and hedge funds held shares of Trevi Therapeutics. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($9.89M), Fairmount Funds Management LLC ($8.77M), Rubric Capital Management LP ($8.75M), VR Adviser LLC ($8.18M), Vanguard Group Inc. ($7.95M), MAI Capital Management ($3.67M), and Opaleye Management Inc. ($3.40M).Learn more on TRVI's institutional investors. What percentage of Trevi Therapeutics stock is owned by institutional investors? 95.76% of Trevi Therapeutics stock is owned by institutional investors. Learn more on TRVI's institutional investor holdings. Which institutional investors have been buying Trevi Therapeutics stock? Of the 22 institutional investors that purchased Trevi Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Fairmount Funds Management LLC ($4.07M), Rubric Capital Management LP ($3.91M), Frazier Life Sciences Management L.P. ($2.93M), Opaleye Management Inc. ($1.31M), Silverarc Capital Management LLC ($980.76K), MAI Capital Management ($498.54K), and Armistice Capital LLC ($448K). How much institutional buying is happening at Trevi Therapeutics? Institutional investors have bought a total of 15,553,214 shares in the last 24 months. This purchase volume represents approximately $27.80M in transactions. Which Trevi Therapeutics major shareholders have been selling company stock? Of the 10 institutional investors that sold Trevi Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: TPG GP A LLC ($4.07M), Rosalind Advisors Inc. ($936.41K), MAI Capital Management ($484.51K), Altium Capital Management LP ($217.84K), BNP Paribas Financial Markets ($111.63K), Trust Co. of Toledo NA OH ($88.36K), and SG Americas Securities LLC ($83.66K). How much institutional selling is happening at Trevi Therapeutics? Institutional investors have sold a total of 6,084,643 shares in the last 24 months. This volume of shares sold represents approximately $11.78M in transactions. Related Companies: LFCR Major Shareholders GALT Major Shareholders ACRV Major Shareholders RIGL Major Shareholders OMER Major Shareholders GBIO Major Shareholders OVID Major Shareholders ATOS Major Shareholders RENB Major Shareholders MACK Major Shareholders This page (NASDAQ:TRVI) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceDems have chosen Biden replacement?Paradigm PressThe Next Industry Being Reshaped By AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchShocking $16T Elon Musk Crypto LeakCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlace[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
